Esophageal Cancer
Download
Report
Transcript Esophageal Cancer
Chief Complaint: DYSPHAGIA
History of Present Illness
5 months
PTA
4 months &
3 weeks PTA
• Experienced dysphagia and vomitting after eating
solid food
• Felt there was a lump in substernal area
• No chest pain
• Persistence of symptoms with weight loss of 10 lbs.
• Consulted a family physician
• Omeprazole, domperidone, disflatyl= did not
provide any relief
4 months &
1 week PTA
4 months &
2 days PTA
• Persistence of symptoms lead him to seek consult at
UST OPD GI-MED
• Advised to stop previous medication and have an
esophagram
• Patient was non-compliant
•
•
•
•
Progressive dysphagia
Unable to ingest soft meals
Difficulty in drinking fluids
Persistence of symptoms+ body weakness= sought
consult and was admitted to our institution (medicine)
Jan.22- Feb.21
EGD- circumferential, nodular, partially obstructing and
friable mass from 35 cm level of esophagus down to the
cardia (41cm level)
Biopsy of esophageal mass- well differentiated squamous
cell carcinoma
Biopsy of cardia of stomach esophageal mass- revealled
esophageal mucosa with severe dysplasia can’t totally
rule out invasive squamous cell carcinoma
Endoscopic guided insertion of NGT done
CT Scan of chest and upper abdomen= soft tissue mass
noted on the esophagus from the distal third up to the
gastroesophageal junction causing significant
narrowing of its lumen (1/26/09)
35th hospital day=started 1st cycle of radiotherapy
and chemotherapy (cisplatin & 5-FU)
CT Scan of whole abdomen= circumferential wall
thickening in the included distal esophagus and
adjacent gastric cardia with thickness ranging from
7-16mm. A solitary lymphadenopathy is seen in
the perigastroesophageal region measuring 1.8x1.4
cm. (4/18/09 other hospital)
CT Scan of the chest= esophageal new growth
involving the middle and lower 3rd of portion with
slight regression (5/6/09)
2 months
PTA
May 10,
2009
• Continued 2nd cycle chemotherapy
& 26th session of radiotherapy
• Subsequently discharged
• Admitted for surgery
Past Medical History
+ for Polio in 1958 at age 3
+ for TB in 1980, 3 months treatment
2002, laceration right upper quadrant, sutured without
any complications
No HPN, DM, allergies, Goiter and Asthma
Family History
+ for colon cancer, sister
+ asthma- siblings, mother, grandmother
+ for DM- mother
+ for PTB- father
Personal & Social History
23 pack years of smoking, stopped 3 months now
Alcoholic beverage drinker (brandy TID, 1 long neck
for 23 years), stopped 5 months now
+ for substance use- tried few sessions of marijuana
and shabu, but denied addiction
Review of Systems
General: (‐) fever/ sweats/anorexia/ weakness
HEENT: (‐) visual dysfunction/redness/ itchiness/ pain/ lacrimation, (‐) deafness/
Hnnitus/ discharge, (‐) bleeding gums/ sores/ fissures/tongue abnormalities/ dental
caries, (‐) sore throat/ tonsillitis, (‐) stiffness/ limitation of motion/ masses/
adenopathy/ sensation of lump in the throat
Pulmonary: (‐) dyspnea/ shortness of breath/ cough/ sputum production/ hemoptysis/
wheezing/ back pain/ chest wall abnormality
Cardiac: (‐) chest pain/ easy fatigability/orthopnea/ nocturnal dyspnea/ palpitations/
syncope/edema/ HPN
Vascular: (‐) phlebitis/ varicosities/ claudication
Gastrointestinal: (‐) nausea/ vomiting/ GI bleeding/ flatulence
Genito‐urinary: (‐) urinary frequency/ urgency/ hesitancy/ dysuria/ hematuria/
nocturia/ urine stream flow abnormality/ flank pain/ stones/urethral discharge/
genital lesions/testicular mass/ perineal pain/ impotence/ vaginal discharge/
abnormal bleeding
Musculoskeletal: (‐) joint stiffness/ pain/ swelling/ muscle pain/ weakness
Endocrine: (‐) heat‐cold intolerance/ thyroid problems/ polyuria polydipsia polyphagia
Psychiatric: (‐) anxiety/ depression/ interpersonal relationship difficulties
Physical Exam
BP (mm Hg): 90/60
Pulse rate / character: 80bpm, regular
Respiratory rate / pattern: 18cpm, regular
Temperature (°C): 36.6°C
Wt. (kg.): 43.5
Ht. (cm): 158.5
BMI: 17.4
GENERAL SURVEY: conscious, coherent, ambulatory
notcardio‐pulmonary distress
SKIN: warm, moist dry skin, no active dermatoses
HEENT: pale palpebral conjunctiva, anicteric sclera,
pupils 2‐3 mm round and ERTL No alar flaring, no
naso‐aural d/c. (+) NGT right Nostril. No impacted
cerumen, intact tympanic bilateral membrane, nasal
septum midline, (‐) tenderness, inflammation (‐)
bleeding, ecchymosis (‐) anosmia, (‐) facial
asymmetry. Moist buccal mucosa, non‐hyperemic
NECK: supple neck, lymph nodes non‐palpable
cervical LN
thyroid gland not enlarged, no other masses
THORAX / LUNGS: symmetrical chest expansion, no
retractions, no lagging, equal tactile fremiti, resonant
lung fields, breath sounds with expiratory wheeze on
both upper lung fields more prominent right
CARDIOVASCULAR: adynamic precordium, AB 5th
LICS MCL,
S1>S2 apex, S2 > S1 at the base, no murmurs
All pulses normal
ABDOMEN: scaphoid abdomen, (+) 6 cm diagonal
scar at
RUQ, normoactive bowel sounds, tympanitic on
percussion, Traube’s space not obliterated, no direct or
rebound tenderness, spleen not palpable (‐) fluid
wave,
(‐) CVA tenderness
MUSCULOSKELETAL: Asymmetric lower extremiHes
(leI
longer and thinner than the right), (‐) tenderness, (‐)
swelling
NEUROLOGIC EXAM: normal
Salient Features
53 years old
Male
BMI: 17.4 (N: 18.5-23)
Progressive dysphagia to solids and liquids
vomiting
Body weakness
(+) family history of colon CA
23 smoking pack years, stopped 5 months ago
Alcoholic
Brandy TID
1 long neck for 23 years, stopped 5 months ago
(+) substance abuse: marijuana,shabu
(-) lymphadenopathies
(-)anorexia
Salient Features
EGD:
circumferential, nodular, partially obstructing and friable mass
from 35cm level of esophagus down to the cardia (41cm level)
Biopsy of esophageal mass
Squamous cell carcinoma well differentiated.
Biopsy of cardia of stomach esophageal mass
Revealed esophageal mucosa with severe dysplasia cannot totally
rule out invasive squamous cell cacinoma (well
differentiated)
Endoscopic guided insertion of NGT
CT Scan of chest & upper abdomen
soft tissue mass noted in the esophagus from the distal third up to
the gastroesophageal junction causing significant narrowing of its
lumen
Salient Features
CT scan of whole abdomen
circumferential wall thickening in the included distal
esophagus and adjacent gastric cardia, with thickness
ranging from 7‐16 mm. A solitary lymphadenopathy is
seen in the perigastroesophageal region measuring 1.8 x
1.4 cm.
CT scan of chest
esophageal new growth involving the middle and lower
third of portion with slight regression
Esophageal Cancer
(Squamous Cell Ca)
Dysphagia
• Difficulty in swallowing, the primary symptom of
esophageal disorders.
• Sensation of sticking or obstruction of the passage of food
through the mouth, pharynx, or esophagus
Harrison’s Principles of Internal Medicine 17th ed. pp 237-239
Dysphagia
Mechanical due to large bolus or narrow lumen
Motor due to weakness of peristaltic contractions or
impaired deglutitive inhibition causing nonperistaltic
contractions and impaired sphincter relaxation
Harrison’s Principles of Internal Medicine 17th ed. pp 237-239
Dysphagia
Mechanical
Oropharyngeal
Esophageal
Motor
Oropharyngeal
Harrison’s Principles of Internal Medicine 17th ed. pp 237-239
Esophageal
Dysphagia
Mechanical
Oropharyngeal
Esophageal
Motor
Oropharyngeal
Harrison’s Principles of Internal Medicine 17th ed. pp 237-239
Esophageal
Esophageal Dysphagia
Normally can be distended up to 4cm in diameter
Dysphagia to solid food <2.5cm
Dysphagia to fluids <1.3cm
.
Harrison’s Principles of Internal Medicine, 17th ed
Squamous Cell Carcinoma of the
Esophagus
Most common type of carcinoma of the esophagus –
90%
Age > 50
Most symptomatic tumors are quite large by the time
they are diagnosed and have already invaded the wall
or beyond
20% -upper third, 50% - middle third, and 30% - lower
third of the esophagus
Robbins and Cotran Pathologic Basis of Disease, 7th ed.
Squamous Cell Carcinoma of the
Esophagus
Most squamous cell carcinomas are moderately to well
differentiated
Rich lymphatic network in the sub mucosa promotes
extensive circumferential and longitudinal spread
Areas of metastasis
upper third - cervical lymph nodes
middle third - mediastinal, paratracheal, and
tracheobronchial nodes
lower third - gastric and celiac groups of nodes
Robbins and Cotran Pathologic Basis of Disease, 7th ed.
Pathogenesis of Esophageal Carcinoma
Injury
Stratified squamous Epithelium
Ulcer
Hyperplasia
Cell
Death
Inflammation
Gastric Metaplasia
Dysplasia
Glandular
Dysplasia
Adenocarcinom
a
Carcinoma
Pathogenesis of Squamous Cell Carcinoma
Injury
Stratified squamous Epithelium
Ulcer
Hyperplasia
p53 gene
mutation
Squamous Cell
Carcinoma
Cell
Death
Inflammation
Dysplasia
Carcinoma
Clinical Features
Insidious in onset
Produces dysphagia and obstruction gradually and late
Patient progressively alters their diet from solid to
liquid foods
Extreme weight loss
Debilitation
Risk Factors
Alcohol consumption increases the risk of
squamous cell cancer 10 to 25 times
Combined cigarette use and alcohol consumption
can increase the risk of squamous cell cancer up to
100-fold
Ingestion of nitrosamines
Contamination of food by specific fungi
Temperature of ingested fluids
Presence of mechanical irritants to the esophagus
Silica
Crushed seeds
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Chronic injury to the esophagus due to:
Caustic ingestion
Stasis of foodstuffs in patients with achalasia
Gastroesophageal acid reflux disease
Familial abnormality that is associated with squamous
cancer of the esophagus
Tylosis A, which carries a 25 percent lifetime risk.
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Enzinger et al NEJM 2003
DIAGNOSTIC TOOLS
OBJECTIVE: To identify and locate the problem, as well as
determine the extent of the diseasE
1.) CBC, PT/APTT, Electrolytes, TPAG
2.)12 lead ECG
3.)Spirometry
4.)Chest Xray
5.)CT scan
CBC - may show anemia secondary to iron
deficiency or chronic disease.
PT and aPTT - may demonstrate hepatic
insufficiency or nutritional deficiencies; also
detects abnormalities in blood clotting
Electrolytes – should be obtained to determine
imbalances, changes in fluid volume occur preop, intra op and post op
Spirometry - measures lung function,
specifically the measurement of the amount
(volume) and/or speed (flow) of air that can be
inhaled and exhaled.
12 lead ECG – a non invasive device that
records electrical activity of the heart as
well as detects possible abnormalities
Chest X-ray – to determine the condition
of the heart and other adjacent structures.
CT scans - best tool for staging; to
exclude the presence of metastases (M
staging) to the lungs and liver;
determines if adjacent structures have
been invaded.
Primary
tumor
Regional
Lymph nodes
Distal
Metastasis
•
•
•
•
•
Tis in situ
T1 Lamina propria,submucosa
T2 Muscularis propria
T3 Adventitia
T4 Adjacent strictures
• N0 none
• N1 Involved
•
•
•
•
M0 none
M1 Distant
M1a Cervical/Celiac LN
M1b Other distant metastasis
(Enzinger et al NEJM 2003)
Esophageal Cancer
6th most frequent tumor disease worldwide
Characterized by rapid development and fatal
prognosis in most cases
Occurrence increases with age with the highest
incidence in the age group 50–70 years
The disease is diagnosed more frequently in males
than in females (3:5)
Most frequent histological type is squamous cell
carcinoma
EPIDEMIOLOGY OF ESOPHAGEAL CANCER – AN OVERVIEW ARTICLE
Department of Preventive Medicine, Faculty of Medicine, Palacky University Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech
Republic
Helena Kollarova et al; March 29, 2007;
Incidence
Esophageal cancer incidence worldwide
462 117 in the year 2002
315 394 cases were diagnosed in males
146 723 cases in females
In males, the incidence is approximately three times
higher than in females.
EPIDEMIOLOGY OF ESOPHAGEAL CANCER – AN OVERVIEW ARTICLE
Department of Preventive Medicine, Faculty of Medicine, Palacky University Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech
Republic
Helena Kollarova et al; March 29, 2007;
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Mortality
Mortality rates represent roughly 90 % of the incidence rates of the
disease.
EPIDEMIOLOGY OF ESOPHAGEAL CANCER – AN OVERVIEW ARTICLE
Department of Preventive Medicine, Faculty of Medicine, Palacky University Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech
Republic
Helena Kollarova et al; March 29, 2007;
Philippines: Mortality 1998
Male 252 per 100 000 (0.7%)
Females 139 per 100 000 (0.4%)
from WHO www.who.int; 1998
Squamous Cell Carcinoma
Squamous cell cancers represent the single most
common malignancy of the esophagus worldwide.
Endemic areas for squamous cell cancer of the
esophagus
Northern littoral in Iran
Linxian,
China
Regions of South Africa, where the incidences are as high as
150 cases per 100,000 population.
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
In the United States
Incidence rate of squamous cell cancers is about 3 per
100,000 population,
Mortality: 12,000 deaths from squamous cell esophageal
cancer in 1998.
Men are more commonly affected than are women
Highest incidence occurs during the sixth through
eighth decades of life
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Complications
Weight Loss
Nutritional Deficiencies
Dysphagia
Solid food impaction
Severe stenosis
Requires endoscopic intervention for disimpaction.
Regurgitation of food or oral secretions
Significant luminal obstruction
Halitosis
Food stasis
Regurgitation
American Medical Network: Esophageal Cancer; James C. Chou et.al
Pulmonary complications from aspiration
Pneumonia
Pulmonary abscess
The tumor mass
Compression
Obstruction of the tracheobronchial tree
Leading to dyspnea, chronic cough, and at times
postobstructive pneumonia.
Esophagoairway fistula may develop with tumor
invasion of the trachea or bronchus.
Airway fistulas are severely debilitating and are
associated with significant mortality owing to the high
risk of pulmonary complications such as pneumonia and
abscess.
TREATMENT
1. Surgical Management (curative)
Treatment of Choice for early cancer
primary goal is complete resection of tumor and involved lymph
nodes
anyone with disease up to T3 N1
must be used with other management to improve survival
esophagectomy: approaches include transthoracic, transhiatal,
transoral route
Radical Resection - Surgical resection that takes the blood
supply and lymph system supplying the organ along with the
organ.
thorascopic tools, laparoscopic tools
gastric/colonic mobilization
Radiation Therapy
The medical use of ionizing radiation as part of cancer treatment
to control malignant cells
Radiotherapy may be used for curative or adjuvant cancer
treatment
May be used as the primary therapy.
Radiation therapy works by damaging the DNA of cells.
The damage is caused by a photon, electron, proton, neutron, or
ion beam directly or indirectly ionizing the atoms which make
up the DNA chain
Chemotherapy
Treatment of cancer through Chemicals
Refers to antineoplastic drugs used to treat cancer or the
combination of these drugs into a cytotoxic standardized
treatment regimen.
Chemotherapy acts by killing cells that divide rapidly, one of the
main properties of cancer cells.
Most chemotherapeutic drugs work by impairing mitosis
It also harms cells that divide rapidly under normal
circumstances which results in the most common side-effects of
chemotherapy.
Some drugs cause cells to undergo apoptosis or programmed cell
death
2. RADIATION & CHEMOTHERAPY
CURABLE DISEASE
Combined is superior to radiation alone
Achieved overall survival rates that equal or exceed
those of historical surgical cohorts (though no trials
comparing them)
Cisplatin and fluorouracil
Radiation with chemotherapy
75% local control rate : improve swallowing
30% actuarial disease free survival rate
18% overall survival rate
High Morbidity from adverse effects
3. Neoadjuvant therapy
Preoperative radiation and chemotherapy then resection
PALLIATIVE THERAPY
Most patient with esophageal cancer have advanced
stage at time of initial medical consultation
<20% survive in 1st year
Goal of Palliation:
improvement of dysphagia
Pain Management
PALLIATIVE THERAPY
DISPLACEMENT THERAPY
ABLATIVE THERAPY
Dilation therapy
Contact thermal
Stenting
Noncontact Thermal
Cytotoxic injection
Photodynamic therapies
DILATION
STENT
PALLIATIVE THERAPY
Bleeding and esophageal fistula are the most common
adverse effects
No improvement of pain and anorexia
Esophageal stent placement can well manage fistulas
from primary malignancy
Enteral Nutrition
Enteral feeding when feasible
Attempt to improve functional status before and after
surgery, during chemoradiation
Oral route: precluded by anorexia, gastric dysmotility,
and generalized debilitation
Surgical jejunostomy
Prognosis
The prognosis of esophageal cancer is generally
unfavorable.
Long-term survival is only approximately 5 % of
patients.
Of patients who undergo radical esophagectomies,10–20
% survive 5 years.
In patients with inoperable cancer, the median survival
is 13–29 months.
EPIDEMIOLOGY OF ESOPHAGEAL CANCER – AN OVERVIEW ARTICLE
Department of Preventive Medicine, Faculty of Medicine, Palacky University Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech
Republic
Helena Kollarova et al; March 29, 2007;